Transmission of hepatitis B virus in correctional facilities--Georgia, January 1999-June 2002
- PMID: 15295311
Transmission of hepatitis B virus in correctional facilities--Georgia, January 1999-June 2002
Abstract
Incarcerated persons have a disproportionate burden of infectious diseases, including hepatitis B virus (HBV) infection. Among U.S. adult prison inmates, the overall prevalence of current or previous HBV infection ranges from 13% to 47%. The prevalence of chronic HBV infection among inmates is approximately 1.0%-3.7%, two to six times the prevalence among adults in the general U.S. population. Incarcerated persons can acquire HBV infection in the community or in correctional settings. This report summarizes the results of 1) an analysis of hepatitis B cases among Georgia inmates reported to the Georgia Department of Human Resources, Division of Public Health (DPH) during January 1999-June 2002, including a retrospective investigation of cases reported during January 2001-June 2002; and 2) a prevalence survey conducted in prison intake centers during February-March 2003. These efforts identified cases of acute hepatitis B in multiple Georgia prisons and documented evidence of ongoing transmission of HBV in the state correctional system. The findings underscore the need for hepatitis B vaccination programs in correctional facilities.
Similar articles
-
Hepatitis B vaccination of inmates in correctional facilities--Texas, 2000-2002.MMWR Morb Mortal Wkly Rep. 2004 Aug 6;53(30):681-3. MMWR Morb Mortal Wkly Rep. 2004. PMID: 15295312
-
Hepatitis B outbreak in a state correctional facility, 2000.MMWR Morb Mortal Wkly Rep. 2001 Jun 29;50(25):529-32. MMWR Morb Mortal Wkly Rep. 2001. PMID: 11446570
-
HIV transmission among male inmates in a state prison system--Georgia, 1992-2005.MMWR Morb Mortal Wkly Rep. 2006 Apr 21;55(15):421-6. MMWR Morb Mortal Wkly Rep. 2006. PMID: 16628181
-
Infection control in jails and prisons.Clin Infect Dis. 2007 Oct 15;45(8):1047-55. doi: 10.1086/521910. Epub 2007 Sep 6. Clin Infect Dis. 2007. PMID: 17879924 Review.
-
A call to immunize the correctional population for hepatitis A and B.Am J Med. 2005 Oct;118 Suppl 10A:84S-89S. doi: 10.1016/j.amjmed.2005.07.025. Am J Med. 2005. PMID: 16271547 Review.
Cited by
-
Serological markers and risk factors associated with Hepatitis B virus infection among Federal Capital Territory prison inmates, Nigeria: Should we be concerned?PLoS One. 2021 Mar 11;16(3):e0248045. doi: 10.1371/journal.pone.0248045. eCollection 2021. PLoS One. 2021. PMID: 33705419 Free PMC article.
-
Epidemiology of hepatitis B--clinical implications.MedGenMed. 2006 Apr 13;8(2):13. MedGenMed. 2006. PMID: 16926752 Free PMC article. Review. No abstract available.
-
Molecular epidemiology and clinical features of Hepatitis C Virus (HCV) in epidemic areas of Interior Sindh, Pakistan.Pak J Med Sci. 2016 Sep-Oct;32(5):1279-1282. doi: 10.12669/pjms.325.10429. Pak J Med Sci. 2016. PMID: 27882036 Free PMC article.
-
Heterogeneity in hepatitis B virus (HBV) seroprevalence estimates from U.S. adult incarcerated populations.Ann Epidemiol. 2009 Sep;19(9):647-50. doi: 10.1016/j.annepidem.2009.04.001. Epub 2009 Jul 12. Ann Epidemiol. 2009. PMID: 19596205 Free PMC article. No abstract available.
-
Nursing case management, peer coaching, and hepatitis a and B vaccine completion among homeless men recently released on parole: randomized clinical trial.Nurs Res. 2015 May-Jun;64(3):177-89. doi: 10.1097/NNR.0000000000000083. Nurs Res. 2015. PMID: 25932697 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical